Possible ligand-receptor interactions for NK1 antagonists as observed in their crystal structures
- 31 March 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 5 (3) , 535-547
- https://doi.org/10.1016/s0968-0896(96)00267-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Discovery of an Orally Bioavailable NK1 Receptor Antagonist, (2S,3S)-(2-Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with Potent Antiemetic ActivityJournal of Medicinal Chemistry, 1995
- Identification of a Series of 3-(Benzyloxy)-1-azabicyclo[2.2.2]octane Human NK1 AntagonistsJournal of Medicinal Chemistry, 1995
- Tryptophan-Derived NK1 Antagonists: Conformationally Constrained Heterocyclic Bioisosteres of the Ester LinkageJournal of Medicinal Chemistry, 1995
- Synthesis of conformationally restricted substance P antagonistsBioorganic & Medicinal Chemistry Letters, 1995
- Articulating a pharmacophore driven synthetic strategy: Discovery of a potent substance P antagonistBioorganic & Medicinal Chemistry Letters, 1994
- Overview: Central & Peripheral Nervous System: Recent advances in the discovery and characterization of substance P antagonistsExpert Opinion on Therapeutic Patents, 1994
- Discovery of a potent substance P antagonist: recognition of the key molecular determinantJournal of Medicinal Chemistry, 1992
- The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine as a novel, nonpeptide substance P antagonistJournal of Medicinal Chemistry, 1992
- The development of versions 3 and 4 of the Cambridge Structural Database SystemJournal of Chemical Information and Computer Sciences, 1991
- A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) ReceptorScience, 1991